Page last updated: 2024-10-31

minoxidil and Myxedema

minoxidil has been researched along with Myxedema in 1 studies

Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.

Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Priestley, GC1
Aldridge, RD1
Sime, PJ1
Wilson, D1

Other Studies

1 other study available for minoxidil and Myxedema

ArticleYear
Skin fibroblast activity in pretibial myxoedema and the effect of octreotide (Sandostatin) in vitro.
    The British journal of dermatology, 1994, Volume: 131, Issue:1

    Topics: Adult; Cell Division; Cells, Cultured; Female; Fibroblasts; Glycosaminoglycans; Humans; Leg Dermatos

1994